Buy & Sell Norwegian Cruise Line Holdings Ltd (NCLH) – Norwegian Cruise Line Holdings Ltd Price Today
Aura AI Summary
Key Stats
- $8.15BMarket Cap
- Consumer CyclicalSector
- -32.29%3M Drawdown
- $23.12BEnterprise Value
- -Dividend Yield
- 1% Buy | 99% SellTrading Activity
- 61 daysTypical Hold Time
Norwegian Cruise Line Holdings Ltd (NCLH) is currently valued at a market capitalization of $8.15B, with an enterprise value of $23.12B. Over the past 52 weeks, Norwegian Cruise Line Holdings Ltd has traded between a low of $16.94 and a high of $26.94, highlighting its annual price range. Over the past three months, Norwegian Cruise Line Holdings Ltd has recorded a drawdown of -32.29%, reflecting recent price volatility. On average, investors hold Norwegian Cruise Line Holdings Ltd for approximately 61 days, indicating typical investor behavior on the platform.
About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Most Recent News
Tarsus Pharmaceuticals to present at three investor conferences in May 2026
Tarsus Pharmaceuticals announced its management will participate in three upcoming investor conferences in May 2026: Bank of America Securities Health Care Conference on May 12, H.C. Wainwright BioConnect Investor Conference on May 19, and Stifel Vir...
Oil prices drop below $100 while gasoline prices hit highest since 2022, boosting refiners' profits.
Crude oil prices fell below $96 a barrel amid ceasefire talks, but gasoline prices rose to $4.56 per gallon, the highest since summer 2022. This divergence is driving refining profit margins, measured by the 3-2-1 crack spread, to a near-record $56.2...
Acumen Pharmaceuticals to present at Bank of America 2026 Health Care Conference on May 14.
Acumen Pharmaceuticals, a clinical-stage biotech company focused on Alzheimer's disease treatments, will participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference on May 14, 2026. The company is advancing its lead d...